Illumina Inc.,ILMN2.68%increase; green up pointing triangle a leading maker of the machines that sequence genes, said Monday it will pay $7.1 billion in cash and stock for a developer of a long ...

Biotech giant Illumina says it will undo its $7.1 billion purchase of the cancer-screening company Grail after losing legal battles with antitrust enforcers in the U.S. and Europe.

U.S. life sciences company Illumina Inc on Tuesday defended its $7.1 billion acquisition of biotech firm Grail Inc , pledging to keep selling its DNA sequencing services to other firms, as it ...

Illumina said Thursday it has won in the Federal Trade Commission's case challenging its $7.1 billion acquisition of cancer detection company GRAIL.

Aug 18 (Reuters) - Illumina Inc , opens new tab has completed its $7.1 billion acquisition of cancer detection test maker Grail Inc , opens new tab, it said on Wednesday amid challenges posed by ...

Illumina Inc.’s was ordered to unwind its $7 billion acquisition of cancer startup Grail by the Federal Trade Commission, an uncommon move by antitrust regulators who said the deal raises ...

The Federal Trade Commission (FTC) on Monday ordered life sciences company Illumina to unwind its $7.1 billion acquisition of cancer detection test developer Grail Inc., citing antitrust concerns.

Illumina Inc. was formally ordered to undo its $7 billion acquisition of cancer-test provider Grail Inc. as the European Union ramped up a legal fight over a deal the firms completed without its ...

The U.S. Securities and Exchange Commission is investigating the $7.1 billion acquisition of Grail, a cancer screening startup, by San Diego’s DNA-sequencing giant Illumina.The San Diego-base… ...

Europe’s antitrust regulator on Tuesday moved to block San Diego’s Illumina from acquiring Grail — one week after a U.S. administrative law judge found that the blockbuster $7.1 billion ...

The Federal Trade Commission said it would seek to block Illumina’s planned $7.1 billion acquisition of a developer of a long-sought blood test that promises to detect cancer early.